These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 347882)

  • 1. Open study with bromperidol (C-C 2489), a new neuroleptic, for the determination of the neuroleptic threshold and the neuroleptic-therapeutic range.
    Haase HJ; Kaumeier S; Schwarz H; Gundel A; Linde OK; Maetz H; Scheel R; Stripf A; Stripf L
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):81-5. PubMed ID: 643910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of female schizophrenic patients with bromperidol, a new neuroleptic drug of the butyrophenone group with medium duration of action.
    Fleischhauer J
    Acta Psychiatr Belg; 1978; 78(1):118-28. PubMed ID: 347874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a clinical trial with bromperidol C-C 2489/21.
    Weiser G
    Acta Psychiatr Belg; 1978; 78(1):102-9. PubMed ID: 347873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open study with bromperidol in hospitalized chronic schizophrenic patients.
    Hermans W
    Acta Psychiatr Belg; 1978; 78(1):89-95. PubMed ID: 347883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial with bromperidol in psychotic states.
    Brasseur R
    Acta Psychiatr Belg; 1978; 78(1):110-7. PubMed ID: 645404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses.
    Benfield P; Ward A; Clark BG; Jue SG
    Drugs; 1988 Jun; 35(6):670-84. PubMed ID: 3048975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic potency of bromperidol.
    Haase HJ; Kaumeier S; Schwarz H; Gundel A; Linde OK; Maetz H; Scheel R; Stripf A; Stripf L
    Acta Psychiatr Belg; 1978; 78(1):83-8. PubMed ID: 347882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The "neuroleptic threshold"--a review of the literature].
    Abraham D; Kissling W; Lauter H
    Psychiatr Prax; 1996 May; 23(3):109-16. PubMed ID: 8710999
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.